What’s happening with the American Roentgen Ray Society? Its annual meeting, known mainly for the quality of its refresher course, has become an essential point of coverage for world-class scientific research as well.
What's happening with the American Roentgen Ray Society? Its annual meeting, known mainly for the quality of its refresher course, has become an essential point of coverage for world-class scientific research as well.Colleagues at Diagnostic Imaging have handled our review of ARRS abstracts in the past, so I was more than a little surprised by the high level of scientific achievement evident at this year's show. I assumed I could breeze through the program to find a newsworthy abstract or two per day for daily news coverage on DiagnosticImaging.com. Was I ever wrong! Three hours passed, and I was still summarizing excellent trials deserving coverage.
Here are a few samples of the scientific papers presented at the 2008 conference:
I could speculate at length about the reasons for why the ARRS meeting presentations have improved to such a degree. The change may reflect the general enrichment of medical imaging research.
The ARRS's improvements may suggest that the RSNA meeting's cup has finally runneth over. Attendees complain year after year that the society's annual conference has grown too large. Important studies that are lost in the shuffle of 100,000 feet in Chicago can earn deserved attention at the smaller ARRS meeting. The globalization of radiological research has also been a generally positive influence.Whatever the cause, the effect has elevated the quality of the ARRS meeting. More than ever, the meeting deserves your attention.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.